Psoriasis affects more than 100 million people worldwide according to the World Health Organization. The number of triggers and associated comorbidities make this immune disorder difficult for patients to manage. As part of Psoriasis Awareness Month, we’re highlighting how UBC’s experts are helping advance treatment options while also focusing on the needs of individual patients.
Understanding risk factors for medication non-adherence is becoming increasingly important in oncology. Patient-reported outcome (PRO) instruments may provide valuable insight on barriers to medication adherence in the real world. A study presented at ISPOR sought to identify and describe key patient-reported risk factors for non-adherence measured in observational studies evaluating adherence with OAAs.
Specialty pharmacy spend continues to grow at a historic rate. As we’ve reported here, 2012 saw an 18.4% increase in spending on specialty medications. While for the first time in 20 years, there was a decrease in U.S. spending on traditional prescription drugs.